NCT03586791

Brief Summary

In this study, the investigators measure a pupil size every 5 minutes during the operation in patients undergoing laparoscopic cholecystectomy under general anesthesia. The investigators would compare the intraoperative opioid consumption and postoperative pain between the group adjusted the anesthetic drug concentration based on the changes of the pupil (Pupil group) and the group based on the changes of a surgical pleth index (SPI group).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2018

Completed
11 days until next milestone

Study Start

First participant enrolled

July 11, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 16, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 29, 2018

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2018

Completed
Last Updated

October 25, 2019

Status Verified

October 1, 2019

Enrollment Period

5 months

First QC Date

June 30, 2018

Last Update Submit

October 24, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Intraoperative opioid consumption

    The amount of remifentanil consumption during the operation is calculated by following equation: Total remifentanil consumption (mcg) / body weight of the patients (kg)/ duration of anesthesia (min)

    During the operation period (Within 2 hour after the anesthesia induction)

  • Peak pain score assessed by numeric rating scale (NRS) in post-anesthesia care unit (PACU)

    Patients are asked to rate their pain according to the numeric rating scale (NRS, 0=no pain to 10= extreme pain imaginable) every 10 min after the PACU admission. Peak pain score is the peak NRS during PACU stay. Higher NRS represents a worse outcome.

    During the PACU stay (Within 1 hour after the PACU admission)

Secondary Outcomes (9)

  • Intraoperative propofol consumption

    During the operation period (Within 2 hour after the anesthesia induction)

  • Intraoperative vasopressor or vasodilator consumption

    During the operation period (Within 2 hour after the anesthesia induction)

  • PACU stay time

    Approximately within 1 hour after the PACU admission

  • Postoperative adverse events

    Approximately within 1 hour after the PACU admission

  • Remnant sedation degree

    Approximately within 1 hour after the PACU admission

  • +4 more secondary outcomes

Other Outcomes (4)

  • Intraoperative pupil change

    Approximately 2 hour after the anesthesia induction

  • Intraoperative SPI change

    Approximately 2 hour after the anesthesia induction

  • Intraoperative mean blood pressure change

    Approximately 2 hour after the anesthesia induction

  • +1 more other outcomes

Study Arms (3)

Pupillometry group

EXPERIMENTAL

In this group, anesthesia is performed using Pupillometry guided anesthesia.

Procedure: Pupillometry guided anesthesia

SPI group

ACTIVE COMPARATOR

In this group, anesthesia is performed using SPI guided anesthesia.

Procedure: SPI guided anesthesia

Control group

SHAM COMPARATOR

In this group, remifentanil concentration is controlled by the discretion of the anesthesiologist in charge of the patients (Standard management).

Procedure: Standard management

Interventions

At least 10 min after anesthesia induction by target-controlled infusion of propofol and remifentanil, baseline values for pupillary diameter is recorded before any surgical procedure. During the operation, propofol effect-site target concentration (Ce) is adjusted to maintain the bispectral index (BIS) value between 40 and 60. Remifentanil Ce is adapted every 5 min based on the changes of pupillary diameter. If the pupillary diameter is increased by more than 30% compared to baseline value, remifentanil concentration is increased by 0.5 ng/ml. If the pupillary diameter is maintained between 5 and 30 % change compared with baseline, remifentanil is not modified. In a case of pupillary diameter is decreased less than 5 % change of baseline, remifentanil concentration is decreased by 0.5 ng/ml.

Also known as: PUPIL
Pupillometry group

During the operation, SPI value should be maintained between 20 and 50 by changing the infusion rate of remifentanil. Even if the SPI is maintained within the target range, the remifentanil infusion rate is increased by 0.5 ng/ml in a case of the SPI value suddenly arises by more than 10.

Also known as: SPI
SPI group

During the operation, propofol effect-site target concentration (Ce) is adjusted to maintain the bispectral index (BIS) value between 40 and 60. Remifentanil concentration is controlled by the discretion of the anesthesiologist in charge of the patients.

Also known as: Control
Control group

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 20 to 65 yr, American Society of Anesthesiologist Physical status(ASA PS) I to II, scheduled for a laparoscopic cholecystectomy under general anesthesia

You may not qualify if:

  • Presence of ophthalmologic diseases such as Horner's syndrome or Sjogren's disease.
  • Presence of neurologic or metabolic diseases
  • Medicated that could interfere with the autonomous nervous system (e.g., b- blockers, anticholinergics)
  • History of substance abuse or psychiatric disease
  • with chronic pain or preoperative analgesics
  • with pacemaker or arrhythmia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eugene Kim

Daegu, Nam-gu, 42472, South Korea

Location

Related Publications (6)

  • Larson MD, Behrends M. Portable infrared pupillometry: a review. Anesth Analg. 2015 Jun;120(6):1242-53. doi: 10.1213/ANE.0000000000000314.

    PMID: 25988634BACKGROUND
  • Huybrechts I, Barvais L, Ducart A, Engelman E, Schmartz D, Koch M. Assessment of thoracic epidural analgesia during general anesthesia using pupillary reflex dilation: a preliminary study. J Cardiothorac Vasc Anesth. 2006 Oct;20(5):664-7. doi: 10.1053/j.jvca.2006.04.004. Epub 2006 Aug 8.

    PMID: 17023285BACKGROUND
  • Sabourdin N, Barrois J, Louvet N, Rigouzzo A, Guye ML, Dadure C, Constant I. Pupillometry-guided Intraoperative Remifentanil Administration versus Standard Practice Influences Opioid Use: A Randomized Study. Anesthesiology. 2017 Aug;127(2):284-292. doi: 10.1097/ALN.0000000000001705.

    PMID: 28719527BACKGROUND
  • Neice AE, Behrends M, Bokoch MP, Seligman KM, Conrad NM, Larson MD. Prediction of Opioid Analgesic Efficacy by Measurement of Pupillary Unrest. Anesth Analg. 2017 Mar;124(3):915-921. doi: 10.1213/ANE.0000000000001728.

    PMID: 27941575BACKGROUND
  • Ledowski T, Burke J, Hruby J. Surgical pleth index: prediction of postoperative pain and influence of arousal. Br J Anaesth. 2016 Sep;117(3):371-4. doi: 10.1093/bja/aew226.

    PMID: 27543532BACKGROUND
  • Kim JH, Jwa EK, Choung Y, Yeon HJ, Kim SY, Kim E. Comparison of Pupillometry With Surgical Pleth Index Monitoring on Perioperative Opioid Consumption and Nociception During Propofol-Remifentanil Anesthesia: A Prospective Randomized Controlled Trial. Anesth Analg. 2020 Nov;131(5):1589-1598. doi: 10.1213/ANE.0000000000004958.

Study Officials

  • Eugene Kim, MD, PhD

    Assistant professor

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

June 30, 2018

First Posted

July 16, 2018

Study Start

July 11, 2018

Primary Completion

November 29, 2018

Study Completion

November 30, 2018

Last Updated

October 25, 2019

Record last verified: 2019-10

Locations